Arteriolar hyalinization predicts delayed graft function in deceased donor renal transplantation

Transplantation

Volumn 86, Issue 7, 2008, Pages 1002-1005

  Matignon, Marie ^a   Desvaux, Dominique ^a   Noël, Laure Hélène ^b   Roudot Thoraval, Françoise ^a   Thervet, Eric ^b   Audard, Vincent ^a   Dahan, Karine ^a   Lang, Philippe ^a   Grimbert, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Arteriolar hyalinization; Deceased donor; Delayed graft function; Renal transplantation

Indexed keywords

ADULT; ARTICLE; COLD ISCHEMIA; DELAYED GRAFT FUNCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HYALINE DEGENERATION; INCIDENCE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; AGED; ANALYSIS OF VARIANCE; ARTERIOLE; BIOPSY; CADAVER; CAUSE OF DEATH; DONOR; GLOMERULUS FILTRATION RATE; KIDNEY; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK FACTOR;

HYALIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERIOLES; BIOPSY; CADAVER; CAUSE OF DEATH; DELAYED GRAFT FUNCTION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYALIN; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS;

EID: 56049113239     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818776b2     Document Type: Article

References (35)

1. Halloran PF, Hunsicker LG. Delayed graft function: State of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001; 1: 115.
2. Boom H, Mallat MJ, de Fijter JW, et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859.
3. Pfaff WW, Howard RJ, Patton PR, et al. Delayed graft function after renal transplantation. Transplantation 1998; 65: 219.
4. Perico N, Cattaneo D, Sayegh MH, et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814.
5. Koning OH, Ploeg RJ, van Bockel JH,et al. Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 1997; 63: 1620.
6. Rosenthal JT, Danovitch GM, Wilkinson A, et al. The high cost of delayed graft function in cadaveric renal transplantation. Transplanta tion 1991; 51: 1115.
7. Yokoyama I, Uchida K, Kobayashi T, et al. Effect of prolonged delayed graft function on long-term graft outcome in cadaveric kidney transplantation. Clin Transplant 1994; 8: 101.
8. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
9. Irish WD, McCollum DA, Tesi RJ, et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003; 14: 2967.
10. Nyberg SL, Matas AJ, Rogers M, et al. Donor scoring system for cadaveric renal transplantation. Am J Transplant 2001; 1: 162.
11. McTaggart RA, Gottlieb D, Brooks J, et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003; 3: 416.
12. Grossberg JA, Reinert SE, Monaco AP, et al. Utility of a mathematical nomogram to predict delayed graft function: A single-center experience. Transplantation 2006; 81: 155.
13. Moore J, Tan K, Cockwell P, et al. Predicting early renal allograft function using clinical variables. Nephrol Dial Transplant 2007; 22: 2669.
14. Remuzzi G, Cravedi P, Perna A, et al. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006; 354: 343.
15. Avihingsanon Y, Ma N, Pavlakis M, et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2005; 16: 1542.
16. Mueller TF, Reeve J,Jhangri GS, et al. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 2008; 8: 78.
17. Gaber LW, Moore LW, Alloway RR, et al. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation 1995; 60: 334.
18. Wang HJ, Kjellstrand CM, Cockfield SM, et al. On the influence of sample size on the prognostic accuracy and reproducibility of renal transplant biopsy. Nephrol Dial Transplant 1998; 13: 165.
19. Randhawa P. Role of donor kidney biopsies in renal transplantation. Transplantation 2001; 71: 1361.
20. Pokorna E, Vitko S, Chadimova M, et al. Proportion of glomeruloscle-rosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. Transplantation 2000; 69: 36.
21. Taub HC, Greenstein SM, Lerner SE, et al. Reassessment of the value of post-vascularization biopsy performed at renal transplantation: The effects of arteriosclerosis. J Urol 1994; 151: 575.
22. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753.
23. Lopes JA, Moreso F, Riera L, et al. Evaluation of pre-implantation kidney biopsies: Comparison of Banff criteria to a morphometric approach. Kidney Int 2005; 67: 1595.
24. Tracy RE, Ishii T. What is 'nephrosclerosis'? Lessons from the US, Japan, and Mexico. Nephrol Dial Transplant 2000; 15: 1357.
25. Tracy RE, Strong JP, Newman WP III, et al. Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25 to 54 years. Kidney Int 1996; 49: 564.
26. Burchfiel CM, Tracy RE, Chyou PH, et al. Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol 1997; 17: 760.
27. Tracy RE, Berenson GS, Cueto-Garcia L, et al. Nephrosclerosis and aortic atherosclerosis from age 6 to 70 years in the United States and Mexico. Virchows Arch A Pathol Anat Histopathol 1992; 420: 479.
28. Smith JP. Hyaline arteriolosclerosis in the kidney. J Pathol Bacteriol 1955; 69: 147.
29. Tracy RE, Tabares Toca V. Nephrosclerosis and blood pressure. II. Reversibility of proliferative arteriosclerosis. Lab Invest 1974; 30: 30.
30. Ueda K, Omae T, Hirota Y, et al. Epidemiological and clinco-pathological study on renal diseases observed in the autopsy cases in Hisayama population, Kyushu Island, Japan. J Chronic Dis 1976; 29: 159.
31. Gamble CN. The pathogenesisof hyaline arteriolosclerosis.Am J Pathol 1986; 122: 410.
32. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002; 62: 1539.
33. Conger JD, Robinette JB, Schrier RW. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 1988; 82: 532.
34. Basile DP. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int 2007; 72: 151.
35. Domanski L, Gryczman M, Pawlik A, et al. Circulating adhesion molecules during kidney allograft reperfusion. Transpl Immunol 2006; 16: 172.